Cargando…

Phase II study of neo-adjuvant chemotherapy for locally advanced gastric cancer

BACKGROUND: Neoadjuvant chemotherapy improves survival of locally advanced gastric cancer patients. However, benefit is limited and the best regimen remains controversial. OBJECTIVES: Our primary objective of this prospective, multicenter phase 2 study was to evaluate the pathological complete respo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Alex Yuang-Chi, Foo, Kian Fong, Koo, Wen-Hsin, Ong, Simon, So, Jimmy, Tan, Daniel, Lim, Khong Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Gastric Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013330/ https://www.ncbi.nlm.nih.gov/pubmed/27648294 http://dx.doi.org/10.1136/bmjgast-2016-000095

Ejemplares similares

Validity of studies suggesting postsurgical chemotherapy for resectable gastric cancer: critical appraisal of randomised trials
por: Manzini, Giulia, et al.
Publicado: (2017)

The putative role of ferroptosis in gastric cancer: a review
por: Wang, Li, et al.
Publicado: (2023)

Deep learning in gastric tissue diseases: a systematic review
por: Gonçalves, Wanderson Gonçalves e, et al.
Publicado: (2020)

Profiling of gastric cancer cell-surface markers to achieve tumour–normal discrimination
por: Toh, Judith, et al.
Publicado: (2020)

Association between proton pump inhibitors after percutaneous coronary intervention and risk of gastric cancer
por: Ng, Andrew Kei-Yan, et al.
Publicado: (2021)

Unique challenges of risk-reducing surgery for hereditary diffuse gastric cancer syndrome: a narrative review
por: Gallanis, Amber F., et al.
Publicado: (2023)

Comparative effectiveness of treatment modalities in non-metastatic gastric adenocarcinoma: a propensity score matching analysis of the National Cancer Database
por: Barzi, Afsaneh, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease with obesity as an independent predictor for incident gastric and colorectal cancer: a population-based longitudinal study
por: Hamaguchi, Masahide, et al.
Publicado: (2019)

Expression and significance of Rac1, Pak1 and Rock1 in gastric carcinoma2
por: Wu, Yong-jun, et al.
Publicado: (2014)

The order of surgery and chemotherapy matters: Multimodality therapy and stage‐specific differences in survival in gastric cancer
por: Ramos‐Santillan, Vicente, et al.
Publicado: (2022)

The morphological and immunohistochemical spectrum of gastric biopsies of patients with absorptive hypercalciuria
por: Declich, Paolo, et al.
Publicado: (2015)

Targeted Therapies for Metastatic Esophagogastric Cancer
por: Reddy, Deepa, et al.
Publicado: (2011)

Advances in Treatment Models of Advanced Gastric Cancer
por: Li, Tao, et al.
Publicado: (2022)

Distinguish the Role of Radiotherapy From Chemoradiotherapy for Gastric Cancer With Behavior of Metastasis-Indolent in Lymph Node
por: Zhi, Yunfei, et al.
Publicado: (2020)

Safety and Feasibility of No.12a Lymph Node Dissection by Portal Vein Approach in Radical Laparoscopic Gastrectomy for Gastric Cancer
por: Huang, Hai-Peng, et al.
Publicado: (2020)

Recent Teaching on Their Surgical Diagnosis and Treatment
Publicado: (1920)

Feasibility of collecting and assessing patient-reported outcomes for emergency admissions: laparotomy for gastrointestinal conditions
por: Kwong, Esther, et al.
Publicado: (2018)

Conventional regression analysis and machine learning in prediction of anastomotic leakage and pulmonary complications after esophagogastric cancer surgery
por: van Kooten, Robert T., et al.
Publicado: (2022)

Detection of sarcopenic obesity and prediction of long‐term survival in patients with gastric cancer using preoperative computed tomography and machine learning
por: Kim, Jaehyuk, et al.
Publicado: (2021)

The Regulatory Mechanism and Research Progress of Ferroptosis in Gastric Cancer
por: Zhang, Zaibo, et al.
Publicado: (2023)

Antibodies Against Epstein–Barr Virus as Disease Markers of Gastric Cancer: A Systematic Review
por: Fontes-Lemus, José I., et al.
Publicado: (2023)

Safety and Efficacy of Carbon Nanoparticle-Labeled Lymph Node Dissection in Radical Resection of Gastric Cancer: A Systematic Review and Meta-Analysis
por: Zhu, Chenglou, et al.
Publicado: (2023)

The emerging landscape of neo/adjuvant immunotherapy in renal cell carcinoma
por: Dibajnia, Pooya, et al.
Publicado: (2023)

Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo-adjuvant chemotherapy
por: Fernanda Amary, M, et al.
Publicado: (2014)

Impact of neoadjuvant therapy followed by laparoscopic radical gastrectomy with D2 lymph node dissection in Western population: A multi‐institutional propensity score‐matched study
por: Bracale, Umberto, et al.
Publicado: (2021)

CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
por: Slagter, Astrid E., et al.
Publicado: (2018)

Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS)
por: Dikken, Johan L, et al.
Publicado: (2011)

Survival After Induction Chemotherapy and Chemoradiation Versus Chemoradiation and Adjuvant Chemotherapy for Locally Advanced Rectal Cancer
por: Kim, Jin K, et al.
Publicado: (2022)

Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy
por: Song, Wu, et al.
Publicado: (2012)

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
por: Findlay, John M., et al.
Publicado: (2016)

Adjuvant radiotherapy and chemotherapy improve survival in patients with pancreatic adenocarcinoma receiving surgery: adjuvant chemotherapy alone is insufficient in the era of intensity modulation radiation therapy
por: Hsieh, Mao‐Chih, et al.
Publicado: (2018)

Practical consensus recommendations for neo-adjuvant chemotherapy in triple negative breast cancer
por: Bhattacharyya, G. S., et al.
Publicado: (2018)

Neo-adjuvant chemotherapy in stage IIIC potentially resectable epithelial ovarian cancer
por: Voutsadakis, Ioannis A.
Publicado: (2016)

Evaluation of the use and efficacy of (neo)adjuvant chemotherapy in angiosarcoma: a multicentre study
por: Constantinidou, Anastasia, et al.
Publicado: (2020)

Genetic variations in triple-negative breast cancers undergoing neo-adjuvant chemotherapy
por: Mori, Miki, et al.
Publicado: (2019)

Impact of oncoplasty in increasing breast conservation rates Post neo-adjuvant chemotherapy
por: Koppiker, Chaitanyanand B., et al.
Publicado: (2023)

Changes in leukoencephalopathy and serum neurofilament after (neo)adjuvant chemotherapy for breast cancer
por: Schroyen, Gwen, et al.
Publicado: (2023)

Tumor expression of survivin, p53, cyclin D1, osteopontin and fibronectin in predicting the response to neo-adjuvant chemotherapy in children with advanced malignant peripheral nerve sheath tumor
por: Karpinsky, Gabrielle, et al.
Publicado: (2018)

Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer – the RAPIDO trial
por: Nilsson, Per J, et al.
Publicado: (2013)

Adjuvant chemotherapy in locally advanced rectal cancer after neo-adjuvant concurrent chemoradiotherapy and surgery: A retrospective study in Vietnamese patients
por: Tran, Thang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ruhi1tar8i8ov5f66oo2lmd842